ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
인공폐 시장의 규모는 최근 급속히 확대하고 있습니다. 2025년 25억 8,000만 달러에서 2026년에는 28억 8,000만 달러로, CAGR 11.6%로 성장이 전망되고 있습니다. 지난 수년간 급성 호흡부전 발생률 증가, 심흉부 수술시 인공심폐장치의 조기 도입, 장기이식 수술 건수 증가, 막 인공폐 기술 개발, 체외생명유지장치 사용 확대 등이 성장 요인으로 꼽히고 있습니다.
인공폐 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 42억 7,000만 달러에 달하며, CAGR은 10.4%에 달할 전망입니다. 예측 기간의 성장 요인으로는 집중치료용 생명유지장치 수요 증가, 휴대용 및 소형 인공폐 시스템에 대한 관심 증가, 첨단 산소화막 소재에 대한 투자 확대, 응급 및 외상 치료 분야에서의 적용 확대, 저침습적 체외 보조 솔루션의 채택 증가 등을 들 수 있습니다. 예측 기간 중 주요 동향으로는 중증 호흡부전 및 중환자 관리에서 인공폐 시스템에 대한 수요 증가, 복잡한 심장 및 폐 이식 수술에서 체외 보조 장치 도입 확대, 이식 대신 저침습적이고 일시적인 폐 보조 수단에 대한 선호도 증가, 응급의료 현장용 휴대용 및 운반용 인공폐 장치의 개발 진전, 효율적인 가스 교환과 장기 보조를 위한 막 기반 인공폐 기술의 적용 확대 등을 들 수 있습니다.
호흡기 질환의 유병률 증가는 향후 수년간 인공폐 시장의 성장을 촉진할 것으로 예측됩니다. 대기오염 악화, 기후 변화, 생활습관 변화 등의 요인이 공중보건에서 호흡기 질환의 부담 증가에 기여하고 있습니다. 인공폐는 혈액에 산소를 공급하고 이산화탄소를 제거하여 손상된 폐 기능을 보조하거나 대체하는 역할을 합니다. 예를 들어 호주의 보건 복지 기관인 호주 보건 복지 연구소(AIHW)에 따르면 2024년 6월 기준 약 850만 명의 호주인(인구의 34%)이 만성 호흡기 질환을 앓고 있는 것으로 추산됩니다. 이 중 천식 환자는 약 280만 명(인구의 11%), 만성폐쇄성폐질환(COPD) 환자는 63만 8,000명(인구의 2.5%)으로 추산됩니다. 이러한 호흡기 질환 증가 추세는 인공폐 시장의 성장을 촉진하고 있습니다.
인공폐 시장에서 사업을 운영하는 주요 기업은 휴대용 공압 ECMO 시스템 등 첨단 솔루션 개발에 주력하고 있으며, 중환자실(ICU)을 넘어 체외식 생명 유지, 신속한 환자 이송, 현장 적용을 촉진하는 것을 목표로 하고 있습니다. 휴대용 공압 ECMO 시스템은 산소 공급 구동식 펌프와 통합 가스 관리 기술을 채택하여 외부 전원이나 대형 전기 부품에 의존하지 않고 체외 산소화 및 순환 보조를 실현합니다. 예를 들어 2024년 5월, 독일 의료기기 제조업체 Hemovent GmbH는 세계 최초의 통합형 휴대용 공압 ECMO 시스템 'MOBYBOX'가 유럽에서 첫 상업적 적용을 완료했다고 발표했습니다. MOBYBOX의 무게는 약 2.5kg이며, 배터리나 모터 없이 산소 공급만으로 작동합니다. 보다 부드러운 혈액 처리와 가스 교환 효율을 향상시키는 바이오닉 플로우(Bionic Flow) 기술을 채택하고 있으며, 초기 시장용 의료기기 규제(MDR) 인증을 획득했습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
An artificial lung is a medical device created to assume the function of natural lungs by supplying oxygen to the blood and eliminating carbon dioxide. It is commonly employed in patients experiencing severe respiratory failure or during surgeries where temporary cessation of heart and lung function is necessary. This technology aims to support or replace lung function, facilitating patient survival and recovery from critical conditions.
The primary types of artificial lungs include single roller pump heart-lung machines, double roller pump heart-lung machines, bubble artificial lungs, and membrane artificial lungs. A single roller pump heart-lung machine operates using a single roller pump to circulate blood through an artificial lung and back into the patient during cardiopulmonary bypass surgery. These machines are utilized in cardiac surgery, lung transplants, acute respiratory failure treatments, and other medical procedures, catering to diverse end users such as hospitals, emergency centers, and healthcare facilities.
Tariffs are influencing the artificial lung market by increasing the cost of imported precision components, membranes, pumps, and control electronics used in heart-lung machines and membrane artificial lung systems, thereby raising overall production and procurement costs for hospitals and emergency care facilities. The most affected segments include membrane artificial lung devices and portable roller pump systems, particularly in regions dependent on international sourcing such as Asia-Pacific and Europe. At the same time, tariffs are encouraging near-shore manufacturing, regional assembly, and supplier diversification, which may support innovation and strengthen supply resilience in the long term across artificial lung product segments.
The artificial lung market research report is one of a series of new reports from The Business Research Company that provides artificial lung market statistics, including artificial lung industry global market size, regional shares, competitors with a artificial lung market share, detailed artificial lung market segments, market trends and opportunities, and any further data you may need to thrive in the artificial lung industry. This artificial lung market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial lung market size has grown rapidly in recent years. It will grow from $2.58 billion in 2025 to $2.88 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to rise in incidence of acute respiratory failure cases, early adoption of heart lung machines in cardiothoracic surgery, growth in organ transplant procedure volumes, development of membrane artificial lung technology, increasing utilization of extracorporeal life support systems.
The artificial lung market size is expected to see rapid growth in the next few years. It will grow to $4.27 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for critical care life-support devices, growing focus on portable and compact artificial lung systems, rising investment in advanced oxygenation membrane materials, expansion of applications in emergency and trauma care, increasing adoption of minimally invasive extracorporeal support solutions. Major trends in the forecast period include increasing demand for artificial lung systems in severe respiratory failure and critical care management, rising adoption of extracorporeal support devices in complex cardiac and lung transplant surgeries, growing preference for minimally invasive and temporary lung support alternatives to transplantation, increasing development of portable and transport-compatible artificial lung units for emergency care settings, expanding use of membrane-based artificial lung technologies for efficient gas exchange and long-term support.
The rising prevalence of respiratory diseases is expected to drive growth in the artificial lung market in the coming years. Factors such as increasing air pollution, climate change, and lifestyle changes have contributed to a growing burden of respiratory conditions on public health. Artificial lungs are employed to support or replace impaired lung function by providing oxygenation and removing carbon dioxide from the blood. For example, in June 2024, according to the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, approximately 8.5 million Australians, or 34% of the population, were estimated to have chronic respiratory conditions. This includes an estimated 2.8 million people (11% of the population) living with asthma and 638,000 people (2.5% of the population) living with chronic obstructive pulmonary disease (COPD). As a result, the growing prevalence of respiratory diseases is propelling the artificial lung market forward.
Major companies operating in the artificial lung market are focusing on developing advanced solutions, such as portable pneumatic ECMO systems, to extend extracorporeal life support beyond the ICU and facilitate rapid patient transport and field deployment. Portable pneumatic ECMO systems use oxygen-supply-driven pumps and integrated gas management to provide extracorporeal oxygenation and circulatory support without dependence on external electric power or heavy motorized components. For instance, in May 2024, Hemovent GmbH, a Germany-based medical device company, announced that MOBYBOX, the world's first integrated portable pneumatic ECMO system, completed its initial commercial applications in Europe. MOBYBOX weighs approximately 2.5 kg, operates solely on oxygen supply without a battery or motor, incorporates Bionique Flow Technology for gentler blood handling and enhanced gas exchange, and has obtained Medical Device Regulation certification for its initial markets.
In August 2024, Getinge AB, a Sweden-based medical technology company, acquired Paragonix Technologies for approximately US$477 million. This acquisition is intended to expand Getinge's organ preservation and transplant logistics portfolio by integrating Paragonix's advanced organ transport and storage systems, thereby improving transplant outcomes and strengthening Getinge's position in cardiac and thoracic transplant workflows. Paragonix Technologies is a US-based company specializing in organ preservation and transport solutions for cardiac and thoracic transplantation.
Major companies operating in the artificial lung market are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co KGaA, ALung Technologies Inc, Xenios AG, Eurosets S.r.l, Nipro Corporation, Braile Biomedica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB-Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare, Cytosorbents Corporation
North America was the largest region in the artificial lung market in 2025. The regions covered in the artificial lung market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the artificial lung market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The artificial lung market consists of sales of extracorporeal membrane oxygenation (ECMO), intravenous membrane oxygenators (IVOX), bioartificial lungs, and microfluidic artificial lungs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Lung Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses artificial lung market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for artificial lung ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial lung market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Increasing Demand For Artificial Lung Systems In Severe Respiratory Failure And Critical Care Management
4.2.2 Rising Adoption Of Extracorporeal Support Devices In Complex Cardiac And Lung Transplant Surgeries
4.2.3 Growing Preference For Minimally Invasive And Temporary Lung Support Alternatives To Transplantation
4.2.4 Increasing Development Of Portable And Transport-Compatible Artificial Lung Units For Emergency Care Settings
4.2.5 Expanding Use Of Membrane-Based Artificial Lung Technologies For Efficient Gas Exchange And Long-Term Support
5. Artificial Lung Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Emergency Centers
5.3 Specialized Cardiac Surgery Centers
5.4 Transplant Care Units
5.5 Other End Users
6. Artificial Lung Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Artificial Lung Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Artificial Lung PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Artificial Lung Market Size, Comparisons And Growth Rate Analysis
7.3. Global Artificial Lung Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Artificial Lung Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Artificial Lung Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Artificial Lung Market Segmentation
9.1. Global Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.3. Global Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospital, Emergency Center, Other End-users
9.4. Global Artificial Lung Market, Sub-Segmentation Of Single Roller Pump Heart Lung Machines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines
9.5. Global Artificial Lung Market, Sub-Segmentation Of Double Roller Pump Heart Lung Machines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global Artificial Lung Market, Sub-Segmentation Of Bubble Artificial Lung, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global Artificial Lung Market, Sub-Segmentation Of Membrane Artificial Lung, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Artificial Lung Market
12.1. China Artificial Lung Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Artificial Lung Market
13.1. India Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Artificial Lung Market
14.1. Japan Artificial Lung Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Artificial Lung Market
15.1. Australia Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Artificial Lung Market
16.1. Indonesia Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Artificial Lung Market
17.1. South Korea Artificial Lung Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Artificial Lung Market
18.1. Taiwan Artificial Lung Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Artificial Lung Market
19.1. South East Asia Artificial Lung Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Artificial Lung Market
20.1. Western Europe Artificial Lung Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Artificial Lung Market
21.1. UK Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Artificial Lung Market
22.1. Germany Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Artificial Lung Market
23.1. France Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Artificial Lung Market
24.1. Italy Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Artificial Lung Market
25.1. Spain Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Artificial Lung Market
26.1. Eastern Europe Artificial Lung Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Artificial Lung Market
27.1. Russia Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Artificial Lung Market
28.1. North America Artificial Lung Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Artificial Lung Market
29.1. USA Artificial Lung Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Artificial Lung Market
30.1. Canada Artificial Lung Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Artificial Lung Market
31.1. South America Artificial Lung Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Artificial Lung Market
32.1. Brazil Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Artificial Lung Market
33.1. Middle East Artificial Lung Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Artificial Lung Market
34.1. Africa Artificial Lung Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Artificial Lung Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Artificial Lung Market Regulatory and Investment Landscape
36. Artificial Lung Market Competitive Landscape And Company Profiles
36.1. Artificial Lung Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Artificial Lung Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Artificial Lung Market Company Profiles
36.3.1. Getinge AB Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
36.3.3. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Fresenius Medical Care AG & Co KGaA Overview, Products and Services, Strategy and Financial Analysis
37. Artificial Lung Market Other Major And Innovative Companies
ALung Technologies Inc, Xenios AG, Eurosets S.r.l, Nipro Corporation, Braile Biomedica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB-Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare
38. Global Artificial Lung Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Artificial Lung Market
40. Artificial Lung Market High Potential Countries, Segments and Strategies
40.1 Artificial Lung Market In 2030 - Countries Offering Most New Opportunities
40.2 Artificial Lung Market In 2030 - Segments Offering Most New Opportunities
40.3 Artificial Lung Market In 2030 - Growth Strategies
